GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medico Remedies Ltd (BOM:540937) » Definitions » Net Interest Income

Medico Remedies (BOM:540937) Net Interest Income : ₹-7 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Medico Remedies Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Medico Remedies's net interest income for the three months ended in Dec. 2023 was ₹-2 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-7 Mil.

Medico Remedies Net Interest Income Historical Data

The historical data trend for Medico Remedies's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medico Remedies Net Interest Income Chart

Medico Remedies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.98 -6.69 -5.00 -5.92 -6.46

Medico Remedies Quarterly Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.00 -1.05 -1.72 -1.82 -2.23

Medico Remedies Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medico Remedies Net Interest Income Related Terms

Thank you for viewing the detailed overview of Medico Remedies's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Medico Remedies (BOM:540937) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medico Remedies Ltd (BOM:540937) » Definitions » Net Interest Income
Comparable Companies
NSE:SAKAR BOM:541400 BOM:506260 BOM:540737 BOM:506414 BOM:532649 BOM:532305 BOM:543329 BOM:524075 BOM:524500 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
MEDICO:India
Address
N. S. Phadke Marg, Opposite Teligali, 1105/1106, 11th Floor, Hubtown Solaris, Andheri (East), Mumbai, MH, IND, 400069
Website
https://www.medicoremedies.com
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It focuses on the production and marketing of anti-infective, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics, and other supplements. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.

Medico Remedies (BOM:540937) Headlines

No Headlines